Cancer Treatment
New Study Reveals How Cancer Reprograms Immune Cells, Offering Hope for Immunotherapy Breakthrough
A study uncovering how cancer cells reprogram immune cells to support tumor growth could improve immunotherapy response rates, which currently fail in 80% of patients.
Vitamin D Supplement Found to Boost Chemotherapy Efficacy in Breast Cancer Patients
A Brazilian clinical trial reveals that daily vitamin D supplementation improves outcomes for women undergoing standard chemotherapy for breast cancer, highlighting a low-cost intervention with global implications.
Study Finds Exercise and Ibuprofen May Alleviate Chemo Brain in Cancer Patients
New research suggests that exercise and the common over-the-counter drug ibuprofen can help combat cognitive decline in cancer patients undergoing chemotherapy and radiation, a condition known as chemo brain.
Telomir Pharmaceuticals Closes TELI Acquisition, Secures Global Rights to Lead Drug Candidate
Telomir Pharmaceuticals completed its acquisition of TELI Pharmaceuticals, obtaining sole global rights to Telomir-1, a drug aimed at treating advanced breast cancer and targeting aging-related diseases, with a $1 million upfront payment and up to $4 million in milestones.
Tonix Pharmaceuticals Presents Preclinical Immuno-Oncology Data at AACR 2026, Highlighting Potential in Gastric Cancer and Immunotherapy
Tonix Pharmaceuticals announced new preclinical data for TNX-1700 and TNX-4700 at AACR 2026, showing potential in gastric cancer and as a BTLA-targeting immunotherapy, which could expand its oncology pipeline.
Novel Urine Test May Predict Bladder Cancer Treatment Response
Researchers have developed a urine test that detects tumor DNA to predict residual bladder cancer after surgery and assess immunotherapy effectiveness.
Compact Proton Therapy Systems Promise Greater Accessibility for Cancer Patients
Innovative compact proton therapy systems are reducing equipment size and costs, potentially making this precise cancer treatment more accessible to patients who previously couldn't access it due to traditional systems' limitations.
Astatine-211 Breakthrough Offers Targeted Cancer Treatment Alternative
Texas A&M University researchers have developed a cancer treatment using astatine-211 that targets malignant cells while sparing healthy tissue, representing a significant advancement in precision radiotherapy.
MIT and Harvard Researchers Develop Enhanced Natural Killer Cell Therapy for Cancer Treatment
Researchers from MIT and Harvard Medical School have engineered modified natural killer cells that show promising results in fighting cancer while avoiding immune system rejection, potentially transforming cancer immunotherapy approaches.
New LED Therapy Shows Promise in Targeting Cancer Cells While Preserving Healthy Tissues
Researchers have developed a novel LED-based cancer treatment that selectively destroys cancer cells while minimizing damage to healthy tissues, potentially offering a more precise alternative to conventional therapies like chemotherapy and radiation.
Oncotelic's 20nm Nanoparticle Technology Enters Human Trials for Enhanced Breast Cancer Treatment
Oncotelic Therapeutics has begun human trials for its 20nm nanoparticle formulation of Everolimus, representing a significant advancement in cancer drug delivery that could dramatically improve tumor targeting and treatment efficacy.
Cancer Treatment Support Needs Drive Biotech Innovation
The emotional and physical challenges faced by cancer patients during treatment are motivating biotech companies like Soligenix to develop new therapeutic approaches while highlighting the importance of patient-focused support strategies.
Glioblastoma Found to Erode Skull Tissue, Challenging Long-Held Treatment Assumptions
A recent study reveals that glioblastoma, the deadliest form of brain cancer, erodes patients' skulls, challenging the long-held assumption that the disease is localized and potentially explaining why current therapies have shown dismal success rates.
Lantern Pharma Champions AI-Driven Reform of 'Broken' Biotech Model at Industry Summit
Lantern Pharma's advocacy for AI platforms to streamline drug development addresses critical industry inefficiencies, potentially accelerating cancer treatments and reducing costs.
UCLA Researchers Awarded $2M Grant for MRI-Guided Cancer Radiation Therapy Study
UCLA Health receives a $2 million grant from ViewRay Systems to advance research on MRI-guided radiation therapy for targeted cancer treatment, highlighting growing investment in precision oncology technologies.
Sturgeon Family Foundation Distributes Over $34,000 to Fort Worth Charities with Focus on Women, Canine Welfare, and Entrepreneurship
The Sturgeon Family Foundation's significant donations to local Fort Worth charities highlight its strategic philanthropic approach across four key focus areas while promoting awareness of alternative cancer treatments through its dedicated website.
Study Links Sucralose Consumption to Reduced Effectiveness of Cancer Immunotherapy
University of Pittsburgh research reveals that regular consumption of the artificial sweetener sucralose may diminish the effectiveness of immunotherapy treatments and reduce survival times in cancer patients.
Calidi Biotherapeutics to Present RedTail Platform at H.C. Wainwright Global Investment Conference
Calidi Biotherapeutics will showcase its innovative RedTail platform at the H.C. Wainwright conference, highlighting its potential to revolutionize cancer treatment through systemic delivery of genetic medicines to metastatic sites.
Columbia University Scientists Develop Bacterial Trojan Horse Method to Deliver Anti-Cancer Viruses
Columbia University researchers have engineered bacteria to deliver cancer-killing viruses directly into tumors, bypassing immune system defenses and potentially revolutionizing cancer treatment approaches.
Breakthrough Lung Cancer Treatment Enhances Chemotherapy with Mitochondrial Transplantation
Researchers in China have developed a novel lung cancer treatment that combines chemotherapy with mitochondrial transplantation to significantly improve treatment efficacy and immune response.
NanoCell Therapeutics' NCtx Platform Could Revolutionize CAR-T Therapy Accessibility
NanoCell Therapeutics' research demonstrates a novel method for in vivo CAR-T cell generation, potentially reducing costs and increasing access to life-saving cancer treatments.
New Machine Learning Model Enhances Cancer Treatment Planning
A collaborative effort between Polish and Brazilian researchers has resulted in a machine learning model that predicts cancer severity, offering a new tool for personalized treatment strategies.
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma
A recent study indicates that a genetically altered herpes virus could offer a new treatment avenue for advanced melanoma, highlighting the potential of oncolytic viruses in cancer therapy.
Calidi Biotherapeutics Featured in NetworkNewsWire Spotlight on Genetic Medicines
Calidi Biotherapeutics' innovative approach to treating hard-to-treat cancers with engineered viruses is highlighted in a NetworkNewsWire editorial, showcasing its potential to transform cancer treatment and address autoimmune disorders.
Creative Biolabs Advances ADC Therapy with Precision Toxin Design and Pharmacokinetic Analysis
Creative Biolabs highlights the intricate balance and design behind ADC therapy, emphasizing the importance of toxin precision and pharmacokinetic studies for effective cancer treatment.
Calidi Biotherapeutics Innovates with Genetic Medicines for Cancer Treatment
Calidi Biotherapeutics Inc. is pioneering a next-generation platform to deliver genetic medicines directly to tumors, offering new hope for hard-to-treat cancers and positioning itself among leading biotech innovators.
Calidi Biotherapeutics Inc. Showcases Breakthrough in Cancer Treatment with Genetic Medicine Platform
Calidi Biotherapeutics Inc. (NYSE American: CLDI) is pioneering a precision genetic medicine platform aimed at revolutionizing cancer treatment by targeting both primary and metastatic tumors with engineered viruses.
Calidi Biotherapeutics' Genetic Medicine Platform Featured in Editorial for Cancer Treatment Innovation
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been highlighted in an editorial for its precision genetic medicine platform, offering a novel approach to targeting cancer tumors amidst rising global diagnoses.
Precision Genetic Medicine Platform Offers New Hope in Cancer Treatment
Calidi Biotherapeutics Inc. is pioneering a novel approach to cancer treatment with its precision genetic medicine platform, targeting both primary tumors and metastatic sites, potentially transforming cancer care and addressing other unmet medical needs.
Siren Biotechnology and RISE Robotics Triumph at Superpowers for Good Live Pitch Q2 2025
Siren Biotechnology and RISE Robotics were recognized for their innovative contributions to cancer treatment and energy-efficient industrial motion systems at the Superpowers for Good Live Pitch, highlighting the event's role in fostering impactful entrepreneurship.